Infliximab therapy in parenchymal neuro‐Behçet’s disease: A single‐center experience

Background Parenchymal neuro‐Behçet’s disease involvement is the most serious complication of Behçet's disease, and no sufficient data on its treatment exists. This study aims to investigate the efficacy and safety of infliximab treatment in neuro‐Behçet’s disease patients with parenchymal invo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of rheumatic diseases 2021-10, Vol.24 (10), p.1302-1307
Hauptverfasser:	Yalcin Kehribar, Demet, Gunaydin, Serkan, Ozgen, Metin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Behcet Syndrome - diagnosis Behcet Syndrome - drug therapy Behcet Syndrome - immunology Behcet's syndrome Behçet's disease Central Nervous System Diseases - diagnosis Central Nervous System Diseases - drug therapy Central Nervous System Diseases - immunology Child Corticosteroids Drug development Female Humans Immunosuppressive agents Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Infliximab Infliximab - adverse effects Infliximab - therapeutic use Male Middle Aged Monoclonal antibodies parenchymal Patients Remission Retrospective Studies Time Factors TNF inhibitors Treatment Outcome Tumor necrosis factor-α Turkey Vein & artery diseases Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!